NCT04173468 is a NA clinical trial of Moblization with Movement in Patellofemoral Syndrome, sponsored by Riphah International University.

Who is sponsoring NCT04173468?

NCT04173468 is sponsored by Riphah International University.

What drugs are being tested in NCT04173468?

Interventions in NCT04173468: Moblization with Movement, Mulligan knee taping.

What condition does NCT04173468 study?

NCT04173468 studies Patellofemoral Syndrome.

Is NCT04173468 still recruiting?

NCT04173468 is currently completed. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT04173468

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobilization With Movement Versus Mulligan Knee Taping Technique on Patellofemoral Pain Syndrome.

Completed NA Last updated 18 January 2020

What this trial tests

NA trial testing Moblization with Movement in Patellofemoral Syndrome in 34 participants. Completed in 31 December 2019.

Timeline

1 September 2019

Primary endpoint
20 December 2019

31 December 2019

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	34
Start date	1 September 2019
Primary completion	20 December 2019
Estimated completion	31 December 2019
Sites	1 location across Pakistan

Drugs / interventions tested

Moblization with Movement
Mulligan knee taping

Conditions studied

Patellofemoral Syndrome — all drugs for Patellofemoral Syndrome →

Sponsor

Riphah International University

Who can join

Adults 20 to 45, any sex, with Patellofemoral Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study intends to determine the effects of MWM verses Mulligan knee taping on patellofemoral pain syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Riphah International University trials

Trials by the same sponsor.

NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04173468 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Riphah International University
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04173468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing